Clinical Trials

Peytant Solutions announced positive pre-clinical outcomes for its AMStent tracheobronchial covered stent system. Dr. Roy Joseph Cho of the University of Minnesota presented the outcomes...

Stimvia announced it completed a clinical study of its peroneal electrical transcutaneous neurmodulation (peroneal eTNM) technology. The Czech Republic-based company delivers peroneal eTNM through its...

Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system. The Acolyte study, a pivotal investigational device...

Fractyl Health announced new data supporting its Revita procedure and priced a new public offering. The data came from the company’s Germany Real-world Registry. It...

The first patient has been treated with InterVene’s Recana thrombectomy system for restoring patency (blood flow) in chronically obstructed deep veins and venous stents. The...

Xvivo announced it enrolled the first patient as part of a continued access protocol (CAP) study for its Heart Assist Transport system. The CAP study...

Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...

The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal trial of its Triadyme-C...

Radical Catheter Technologies™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next generation of endovascular access...